Related Experiment Video
Updated: Aug 18, 2026
Quantitative Analysis of Cancer Metastasis using an Avian Embryo Model
Published on: May 31, 2011
[Inhibition of tumor cell metastasis in chick embryo by beta 1 integrin antisense oligonucleotide]
I Ninomiya1, Y Endo, Y Yonemura
1Department of Surgery II, School of Medicine, Kanazawa University.
Abstract:
The antimetastatic effect of integrin beta 1 subunit antisense oligonucleotide on human fibrosarcoma cell (HT-1080) in chick embryo was examined. Phosphorothioate modified antisense oligonucleotide (B1-1) was designed to hybridize specifically to integrin beta 1 subunit mRNA. Pretreatment of HT-1080 cells with B1-1 decreased the metastatic ability in chick embryonic liver and lung, while B1-1 showed no toxicity to HT-1080 nor chick embryo. Western blot analysis showed a reduction of the amount of cell surface integrin beta 1 subunit. B1-1 also inhibited HT-1080 attachment to laminin and fibronectin. These results indicate that the inhibition of tumor cell attachment by antisense oligonucleotide might be a good approach to the prevention of cancer metastasis.
Insights
Antisense oligonucleotide targeting integrin beta 1 subunit reduced cancer cell metastasis in chick embryos without toxicity. This approach shows promise for preventing cancer spread by inhibiting tumor cell attachment.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Cancer metastasis remains a significant challenge in oncology.
- Integrin beta 1 subunit plays a crucial role in tumor cell adhesion and migration.
- Targeting specific molecular pathways offers potential therapeutic strategies.
Purpose of the Study:
- To investigate the antimetastatic effect of an antisense oligonucleotide against the integrin beta 1 subunit.
- To evaluate the efficacy and safety of this approach in a preclinical model.
Main Methods:
- Development of a phosphorothioate-modified antisense oligonucleotide (B1-1) targeting integrin beta 1 subunit mRNA.
- Treatment of human fibrosarcoma cells (HT-1080) with B1-1.
- Assessment of metastatic ability in chick embryo models.
- Western blot analysis to confirm target engagement.
- In vitro cell attachment assays using laminin and fibronectin.
Main Results:
- B1-1 significantly decreased the metastatic potential of HT-1080 cells in chick embryonic liver and lung.
- No observable toxicity of B1-1 to HT-1080 cells or chick embryos was detected.
- Western blot confirmed a reduction in cell surface integrin beta 1 subunit expression.
- B1-1 inhibited HT-1080 cell attachment to extracellular matrix proteins like laminin and fibronectin.
Conclusions:
- Antisense oligonucleotide therapy targeting integrin beta 1 subunit demonstrates significant antimetastatic effects.
- Inhibition of tumor cell attachment via antisense oligonucleotides is a viable strategy for cancer metastasis prevention.
- This approach offers a potentially safe and effective method for combating cancer spread.
